| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |